No phaseRecruiting

Evaluation of a Mobile Menopause Application (EMMA)

Sponsor
Endo Health GmbH (Industry)
Enrolment
426 planned
Conditions
N95.1 Menopausal and Female Climacteric States
Interventions
Menopause App
Ages
adults, older adults
Registry
NCT07663305

From the registry

This study examines whether a digital app can help women manage symptoms of menopause. A total of 426 women with medically confirmed menopausal symptoms are randomly assigned to either use the app in addition to their usual medical care for 24 weeks, or to continue with usual care alone. The app provides evidence-based content and exercises for multimodal menopause management. Participants are followed up over 24 weeks, with the primary outcome assessed at 12 weeks. The main goal is to evaluate whether the app improves menopause-specific quality of life.

Primary outcomes

  • Menopause-specific quality of life
Full record on ClinicalTrials.gov